Abstract
A rare disease is defined as a condition that affects fewer than 200,000 people. Yet cumulatively, rare diseases affect over 25 million individuals in the United States. Treatments for the over 7,000 rare diseases have historically lacked pharmaceutical development due to the high cost of research and potential loss of profits (Roberts & Wadhwa, 2025; Haendel et al., 2020).
